Want to join the conversation?
$CELG 2Q15 Call: ABRAXANE posted strong 9% sequential growth & 13% year-over-year growth driven primarily by ongoing launch of pancreatic cancer across Europe. We also launched ABRAXANE in non-small-cell lung cancer in Europe. We expect solid future growth in Europe for ABRAXANE.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.